DIHYDROCHROMENDERIVATE

European patent · EP3770162 · In force

Register entry

Publication number
EP3770162
Application number
EP19770755
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 19, 2019
Published
Jan 27, 2021
Granted
Mar 15, 2023
Protection ends at the latest
Mar 18, 2039
Next annual fee due
Mar 31, 2027
IPC classes
C07D 491/20 (2006.01)
A61K 31/436 (2006.01)
A61P 35/00 (2006.01)
Priority
JP 2018052971 20.03.2018
PCT application
PCT/JP2019/011439 19.03.2019
PCT publication
WO2019/181939 26.09.2019
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Jan 24, 2024

    Change

    Published in Swissreg on 24.01.2024

  5. May 11, 2023

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 11.05.2023

  6. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  7. Mar 15, 2023

    Granted

    Published in Swissreg on 15.03.2023

Parties

Holder

Sumitomo Pharma Co., Ltd.

6-8, Doshomachi 2-chome Chuo-ku, Osaka-shi,, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

BAN, Hitoshi

Osaka-shi, Osaka 554-0022, JP

KAMIOKA, Seiji

Osaka-shi, Osaka 554-0022, JP

HASHIZUME, Miki

Osaka-shi, Osaka 554-0022, JP

SAWAYAMA, Yusuke

Osaka-shi, Osaka 554-0022, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.